A review of the last decade: pancreatic cancer and type 2 diabetes

被引：1
|
作者：
Wu, Jiaqi [1 ,2 ]
Tang, Liang [3 ]
Zheng, Feng [4 ]
Chen, Xun [5 ,6 ]
Li, Lei [7 ]
机构：
[1] Southern Med Univ, Nanfang Hosp, Guangzhou, Peoples R China
[2] Southern Med Univ, Sch Nursing, Guangzhou, Peoples R China
[3] Zhuzhou Cent Hosp, Dept Gen Med, Zhuzhou, Peoples R China
[4] Univ Otago, Dept Anat, Dunedin, New Zealand
[5] Zhuzhou Cent Hosp, Dept Trauma Ctr, 116 Changjiang Rd, Zhuzhou 412000, Peoples R China
[6] Zhuzhou Cent Hosp, Dept Hepatobiliary Surg, 116 Changjiang Rd, Zhuzhou 412000, Peoples R China
[7] Univ Otago, Dept Pathol, Dunedin 9016, New Zealand
来源：
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY | 2024年 / 130卷 / 06期
关键词：
Pancreatic cancer; type; 2; diabetes; relationship; 10; years; drugs; SIGNALING PATHWAY; SGLT2; INHIBITORS; CLINICAL-USE; P38; MAPK; PROMOTES; CELLS; PROGRESSION; MECHANISMS; OBESITY; RAGE;
D O I：
10.1080/13813455.2023.2252204
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Pancreatic cancer (PC) is a prevalent gastrointestinal tumour known for its high degree of malignancy, resulting in a mere 10% five-year survival rate for most patients. Over the past decade, a growing body of research has shed light on the intricate bidirectional association between PC and Type 2 diabetes (T2DM). The collection of PC- and T2DM-related articles is derived from two comprehensive databases, namely WOS (Web of Science Core Collection) and CNKI (China National Knowledge Infrastructure). This article discusses the last 10 years of research trends in PC and T2DM and explores their potential regulatory relationship as well as related medications.
引用
收藏
页码：660 / 668
页数：9
相关论文
共 50 条
  • [21] Type 2 diabetes: induced MMPs promote pancreatic cancer progression
    Tingting, X.
    Shenghong, J.
    DIABETOLOGIA, 2017, 60 : S566 - S567
  • [22] Anti-Hyperglycemic Agents for the Treatment of Type 2 Diabetes Mellitus: Role in Cardioprotection During the Last Decade
    Kocyigit, Duygu
    Gurses, Kadri Murat
    Yalcin, Muhammed Ulvi
    Tokgozoglu, Lale
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2017, 17 (01) : 19 - 31
  • [23] Active SLAM: A Review on Last Decade
    Ahmed, Muhammad Farhan
    Masood, Khayyam
    Fremont, Vincent
    Fantoni, Isabelle
    SENSORS, 2023, 23 (19)
  • [24] Morphometric studies in human pancreatic cancer argues against the etiological role of type 2 diabetes in pancreatic cancer
    Saruc, Murat
    Iki, Katsumichi
    Pour, Parviz M.
    HISTOLOGY AND HISTOPATHOLOGY, 2010, 25 (04) : 423 - 432
  • [25] HISTORY OF PSYCHOLOGY - REVIEW OF LAST DECADE
    MARX, OM
    JOURNAL OF THE HISTORY OF THE BEHAVIORAL SCIENCES, 1977, 13 (01) : 41 - 47
  • [26] The past decade in type 2 diabetes and future challenges
    Haddad, Jihad A.
    Haddad, Aiman N.
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2018, 17 (04): : 451 - 459
  • [27] The past decade in type 2 diabetes and future challenges
    Jihad A. Haddad
    Aiman N. Haddad
    Hormones, 2018, 17 : 451 - 459
  • [28] Coffee, type 2 diabetes and pancreatic islet function - A mini-review
    Costabile, Adele
    Sarnsamak, Kittiwadee
    Hauge-Evans, Astrid C.
    JOURNAL OF FUNCTIONAL FOODS, 2018, 45 : 409 - 416
  • [29] A Systematic Review of Exocrine Pancreatic Insufficiency Prevalence and Treatment in Type 1 and Type 2 Diabetes
    Lewis, Dana M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 (09) : 659 - 672
  • [30] The relationship between pancreatic cancer and type 2 diabetes: the Fremantle Diabetes Study Phase I
    Davis, Timothy M. E.
    Davis, Wendy A.
    INTERNAL MEDICINE JOURNAL, 2022, 52 (07) : 1258 - 1262
12345